Aditxt (ADTX) Other Non-Current Liabilities (2024 - 2026)
Aditxt (ADTX) recorded quarterly Other Non-Current Liabilities of $35.5 million in Q1 2026, up 403.93% quarter-over-quarter from $7.0 million in Q4 2025, and up 2583772.81% on a YoY basis from N/an in Q1 2025.
Aditxt (ADTX) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
Aditxt's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $35.5 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 2583772.81% year-over-year to $35.5 million; the TTM figure through Mar 2026 stood at $35.5 million (up 2583772.81% YoY), while the FY2025 annual figure was $7.0 million, up 48359.84% from the prior year.
- Other Non-Current Liabilities was $35.5 million for Q1 2026 at Aditxt, up from $7.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $35.5 million in Q1 2026 to a low of $230.0 in Q3 2025.
- Historically, Other Non-Current Liabilities has averaged $6.1 million across 3 years, with a median of $14517.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities slumped 99.95% in 2025, then jumped 2583772.81% in 2026.
- A 3-year view of Other Non-Current Liabilities shows it stood at $14517.0 in 2024, then surged by 48359.84% to $7.0 million in 2025, then soared by 403.93% to $35.5 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $35.5 million (Q1 2026), $7.0 million (Q4 2025), and $230.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.45 Mn |
| Dec 31, 2025 | 7.03 Mn |
| Sep 30, 2025 | 230.00 |
| Jun 30, 2025 | 392.00 |
| Mar 31, 2025 | 1,372.00 |
| Dec 31, 2024 | 14,517.00 |
| Sep 30, 2024 | 429,018.00 |